Disappointment facing patients with breast cancer as trastuzumab deruxtecan too expensive for NHS.

Elizabeth Gourd

Published in: The Lancet. Oncology (2024)

Keyphrases

epidermal growth factor receptor
patient safety
metastatic breast cancer
tyrosine kinase
quality improvement